With evidence-based smartphone apps developed by our Center for Behavioral Intervention Technologies, mental healthcare is always within reach.
A new pathway in the brain can be manipulated to alleviate depression, offering a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
By targeting a hub of schizophrenia-related genes, Northwestern Medicine scientists were able to correct a disease-related alteration in mouse model neurons.
Herbert Meltzer, MD, professor of Psychiatry and Behavioral Sciences, Pharmacology and Physiology, has been chosen to receive a Pioneer in Psychopharmacology Award from the International College of Neuropsychopharmacology.
Smartphone conversational agents like Apple’s Siri respond to questions about health crises inconsistently and incompletely, according to a recent study.
Genetic factors and the environment cause depression via different molecular pathways in rats, according a new Northwestern Medicine study.
SchizConnect, the first neuroimaging meta-database dedicated to clinical schizophrenia research, will allow scientists to see broader results across many more subjects than ever before.
Northwestern Medicine scientists received a five-year, $3.9 million grant from the National Institutes of Health to determine the optimal drug doses for treating pregnant women with depression.
Northwestern Medicine scientists have discovered for the first time the neurotransmitter pathways that allow stressful fear-related memories become consciously inaccessible.
Scientists at Northwestern University are using a novel dimensional method for distinguishing misbehavior that is expectable in early childhood versus that which is cause for clinical concern.